What are the differences between pulmonary hypertension and essential (systemic) hypertension?

Pulmonary Hypertension vs Essential Hypertension: Key Differences

Pulmonary hypertension and essential (systemic) hypertension are fundamentally different diseases affecting separate circulatory systems—the pulmonary circulation versus the systemic circulation—with distinct definitions, pathophysiology, organ involvement, and clinical consequences.

Anatomical and Hemodynamic Distinctions

Circulatory System Affected

• Pulmonary Hypertension (PH): Affects the pulmonary arterial circulation (right heart → lungs)
• Essential Hypertension: Affects the systemic arterial circulation (left heart → body)

Hemodynamic Definitions

Pulmonary Hypertension is defined hemodynamically as mean pulmonary arterial pressure (mPAP) ≥25 mmHg at rest measured by right heart catheterization 1. Normal mean pulmonary arterial pressure is 14-20 mmHg 2.

Essential Hypertension involves elevated systemic arterial blood pressure, typically defined as systolic BP ≥140 mmHg and/or diastolic BP ≥90 mmHg measured in the brachial artery 3.

Pressure Differences

The pulmonary circulation is a low-pressure, low-resistance system compared to the high-pressure systemic circulation 4. This fundamental anatomical difference means:

• Normal pulmonary pressures are much lower than systemic pressures
• The pulmonary arterial system has compliance distributed throughout the entire vascular tree
• The systemic arterial tree has compliance mainly in the aorta (80% in thoracic-abdominal aorta) 4

Clinical Classification and Etiology

Pulmonary Hypertension

PH encompasses five major clinical groups with diverse etiologies 1:

1. Group 1: Pulmonary arterial hypertension (PAH) - includes idiopathic, heritable, drug-induced, and associated conditions (connective tissue disease, HIV, portal hypertension, congenital heart disease)
2. Group 2: PH due to left heart disease
3. Group 3: PH due to lung diseases and/or hypoxia
4. Group 4: Chronic thromboembolic PH
5. Group 5: PH with unclear/multifactorial mechanisms

Essential Hypertension

Essential hypertension represents primary systemic hypertension without identifiable secondary cause, accounting for approximately 90% of systemic hypertension cases 3. It involves complex interactions between environmental factors, genes, hormonal networks, and multiple organ systems.

Pathophysiology

Pulmonary Hypertension involves progressive increase in pulmonary vascular resistance leading to right ventricular failure 5, 1. The pathological changes include pulmonary microcirculation obstruction and remodeling.

Essential Hypertension involves dysregulation of renal, cardiovascular, and central nervous systems, with vascular and immune mechanisms contributing to elevated systemic vascular resistance 3.

Organ Damage Patterns

Pulmonary Hypertension

• Primary impact: Right ventricle (right ventricular hypertrophy and failure)
• Consequences: Right heart failure, syncope, peripheral edema, hepatomegaly, ascites 2
• Prognosis: Without treatment, leads to right ventricular failure and death 2

Essential Hypertension

• Primary impact: Left ventricle and systemic organs
• Consequences: Hypertension-mediated organ damage (HMOD) affecting heart (left ventricular hypertrophy), brain (stroke), kidneys (chronic kidney disease), eyes (retinopathy), and vessels 3

Critical Clinical Distinction

These are separate disease entities that generally do not coexist as related conditions. Research demonstrates that in patients with World Health Organization stages I-II essential hypertension, there is neither primary nor secondary effect of systemic hypertension on the pulmonary vasculature 6. The pulmonary vascular resistance in essential hypertension patients is not significantly related to systemic blood pressure 6.

Diagnostic Approach

Pulmonary Hypertension requires right heart catheterization for definitive diagnosis, with echocardiography as initial screening 2, 1.

Essential Hypertension is diagnosed through repeated office blood pressure measurements, with ambulatory or home blood pressure monitoring for confirmation 3.

Common Pitfall to Avoid

Do not assume that systemic hypertension causes or is associated with pulmonary hypertension. While Group 2 PH can occur secondary to left heart disease (which may include hypertensive heart disease with left ventricular dysfunction), this represents a specific secondary form of PH, not a direct relationship between essential hypertension and pulmonary vascular disease 1.